Published in Biochem J on June 01, 1974
Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. Br J Pharmacol (1975) 1.38
The metabolism of 5-hydroxytryptamine and beta-phenylethylamine in perfused rat lung and in vitro. Br J Pharmacol (1979) 1.07
Purification and immunochemical characterization of monoamine oxidase from rat and human liver. Biochem J (1977) 1.01
Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B. Br J Pharmacol (1981) 0.96
Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase 'type B' in lung. Br J Pharmacol (1976) 0.94
The primary structure of bovine monoamine oxidase type A. Comparison with peptide sequences of bovine monoamine oxidase type B and other flavoenzymes. Biochem J (1989) 0.90
Oxidation of 3-amino-1-phenylprop-1-enes by monoamine oxidase and their use in a continuous assay of the enzyme. Biochem J (1988) 0.83
Rat liver mitochondrial monoamine oxidase. A change in the reaction mechanism on solubilization. Biochem J (1975) 0.81
Modelling the roles of MAO and SSAO in glucose transport. J Neural Transm (Vienna) (2007) 0.78
Effects of oestrous cycle and exogenous ovarian steroids on 5-hydroxytryptamine metabolism in rat lung. J Physiol (1979) 0.76
The influence of respiratory state on monoamine oxidase activity in rat liver mitochondria. Biochem J (1978) 0.75
Some characteristics of the metabolism of beta-phenylethylamine in rat isolated lung [proceedings]. Br J Pharmacol (1977) 0.75
Rate-limiting step in the metabolism of polar and non-polar monoamines in lung and liver. Br J Pharmacol (1982) 0.75
Biochemical and behavioural studies of monoamine oxidase inhibition. Ir J Med Sci (1978) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The determination of enzyme inhibitor constants. Biochem J (1953) 27.58
The oxidation of adrenaline and other amines. Biochem J (1937) 24.60
An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol (1967) 12.04
Tyramine oxidase. Biochem J (1937) 6.47
Purification of amine oxidase from beef plasma. J Biol Chem (1954) 4.79
Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol (1968) 4.45
Oxidation of amines by animal tissues. Biochem J (1937) 2.58
Further studies on the inhibition of monoamine oxidase by M and B 9302 (clorgyline). I. Substrate specificity in various mammalian species. Biochem Pharmacol (1969) 1.73
Multiple forms of human brain mitochondrial monoamine oxidase. Nature (1970) 1.69
The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidase. Biochem J (1973) 1.47
Occurrence and properties of monoamine oxidase in adrenergic neurons. J Neurochem (1971) 1.46
Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species. Adv Biochem Psychopharmacol (1972) 1.43
COMPARATIVE STUDIES IN THE CHARACTERIZATION OF MONOAMINE OXIDASES. Proc Soc Exp Biol Med (1963) 1.21
Allotopic properties of human brain monoamine oxidase. Nat New Biol (1973) 1.04
The reaction pathway of membrane-bound rat liver mitochondrial monoamine oxidase. Biochem J (1973) 1.03
Multiple monoamine oxidases in rat liver mitochondria. Can J Biochem (1970) 1.02
PARTIAL SEPARATION OF RAT LIVER MITOCHONDRIAL AMINE OXIDASES. Nature (1963) 0.99
The kinetics of phenethylhydrazine oxidation by monoamine oxidase. Biochem J (1971) 0.93
Neuronal monoamine oxidase: specific enzyme types and their rates of formation. Adv Biochem Psychopharmacol (1972) 0.93
The catabolism of catecholamines. Recent studies. Br Med Bull (1973) 0.90
Some properties of monoamine oxidase. Adv Biochem Psychopharmacol (1972) 0.88
Human liver mitochondrial monoamine oxidase. 3. Kinetic studies concerning time-dependent inhibitions. Biochemistry (1969) 0.88
Multiple forms of mitochondrial monoamine oxidase. Br Med Bull (1973) 0.87
Human liver mitochondrial monoamine oxidase. I. Kinetic studies of model interactions. J Biol Chem (1968) 0.87
The flavin prosthetic group of purified rat liver mitochondrial monoamine oxidase. Adv Biochem Psychopharmacol (1972) 0.87
Multiple forms of rat brain mitochondrial monoamine oxidase. Subcellular localization. FEBS Lett (1972) 0.86
Action of rat liver monoamine oxidase on multiple substrates. Arch Biochem Biophys (1955) 0.86
Mapping of the active sites of transglutaminases. II. Activity of the guinea pig liver enzyme toward methylglutamine peptide derivatives. J Biol Chem (1973) 0.78
Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production. Nature (1986) 3.41
mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J (2001) 2.86
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics (1997) 2.55
Negatively co-operative ligand binding. Biochem J (1973) 2.36
Cholesterol is excluded from the phospholipid annulus surrounding an active calcium transport protein. Nature (1975) 2.30
Activation of two signal-transduction systems in hepatocytes by glucagon. Nature (1986) 2.21
A peripheral and an intrinsic enzyme constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes. Biochem J (1980) 2.14
The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it. Biochim Biophys Acta (1976) 2.07
Annular lipids determine the ATPase activity of a calcium transport protein complexed with dipalmitoyllecithin. Biochemistry (1976) 2.06
Is an early calcium flux necessary to stimulate lymphocytes? Nature (1977) 2.03
Kinetic analysis of progress curves. Methods Enzymol (1979) 1.98
A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway. Proc Natl Acad Sci U S A (1997) 1.95
Abolition of the expression of inhibitory guanine nucleotide regulatory protein Gi activity in diabetes. Nature (1987) 1.93
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br J Pharmacol (2009) 1.89
The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579. EMBO J (1999) 1.85
Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes. Biochem J (1983) 1.82
The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform. J Biol Chem (1999) 1.77
Effects of pH on enzymes. Methods Enzymol (1979) 1.77
Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping. Pharmacogenetics (1999) 1.74
ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions. J Biol Chem (2000) 1.68
The sub-mitochondrial localization of monoamine oxidase in rat liver and brain. Biochim Biophys Acta (1967) 1.62
Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes. Biochem J (1981) 1.58
Challenge of hepatocytes by glucagon triggers a rapid modulation of adenylate cyclase activity in isolated membranes. Biochem J (1983) 1.53
Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem J (1997) 1.51
Changes in the form of Arrhenius plots of the activity of glucagon-stimulated adenylate cyclase and other hamster liver plasma-membrane enzymes occurring on hibernation. Biochem J (1978) 1.51
Inhibition of monoamine oxidase by amphetamine and related compounds. Biochem Pharmacol (1976) 1.49
The increase in bilayer fluidity of rat liver plasma membranes achieved by the local anesthetic benzyl alcohol affects the activity of intrinsic membrane enzymes. J Biol Chem (1980) 1.49
The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidase. Biochem J (1973) 1.47
cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model. Biochem J (1998) 1.46
Exchange of partners in glucagon receptor-adenylate cyclase complexes. Physical evidence for the independent, mobile receptor model. Biochim Biophys Acta (1977) 1.46
The insulin receptor tyrosyl kinase phosphorylates holomeric forms of the guanine nucleotide regulatory proteins Gi and Go. FEBS Lett (1987) 1.46
A simple method for sequencing small DNAs by introducing precise overlapping ends into restriction digestion fragments. Nucleic Acids Res (1998) 1.40
Guanine-nucleotide-binding proteins expressed in rat white adipose tissue. Identification of both mRNAs and proteins corresponding to Gi1, Gi2 and Gi3. Biochem J (1989) 1.37
Mutant but not normal p21 ras elevates inositol phospholipid breakdown in two different cell systems. Oncogene (1988) 1.37
Hormonal regulation of Gi2 alpha-subunit phosphorylation in intact hepatocytes. Biochem J (1990) 1.37
Insulin inhibits the cholera-toxin-catalysed ribosylation of a Mr-25000 protein in rat liver plasma membranes. Biochem J (1985) 1.35
The lipid environment of the glucagon receptor regulates adenylate cyclase activity. Biochim Biophys Acta (1976) 1.34
Insulin trigger, cyclic AMP-dependent activation and phosphorylation of a plasma membrane cyclic AMP phosphodiesterase. Nature (1980) 1.34
Insulin exerts actions through a distinct species of guanine nucleotide regulatory protein: inhibition of adenylate cyclase. Biochem J (1983) 1.32
The reaction pathway of pig brain mitochondrial monoamine oxidase. Eur J Biochem (1968) 1.31
The kinetics of pig brain aldehyde dehydrogenase. Eur J Biochem (1971) 1.29
Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. J Pharmacol Exp Ther (1997) 1.29
The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Mol Psychiatry (2010) 1.28
The activity of glucagon-stimulated adenylate cyclase from rat liver plasma membranes is modulated by the fluidity of its lipid environment. Biochem J (1978) 1.27
Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases. Br J Pharmacol (2000) 1.27
The purification of pig brain mitochondrial monoamine oxidase. Eur J Biochem (1968) 1.27
Diabetes-induced alterations in the expression, functioning and phosphorylation state of the inhibitory guanine nucleotide regulatory protein Gi-2 in hepatocytes. Biochem J (1990) 1.25
Forskolin and ethanol both perturb the structure of liver plasma membranes and activate adenylate cyclase activity. Biochem Pharmacol (1983) 1.23
Characterization of the phosphorylated form of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes. Biochem J (1981) 1.23
Purification of glutamate dehydrogenase from ox brain and liver. Evidence that commercially available preparations of the enzyme from ox liver have suffered proteolytic cleavage. Biochem J (1980) 1.21
Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. Biochem J (1986) 1.21
Cholera toxin mediated activation of adenylate cyclase in intact rat hepatocytes. FEBS Lett (1979) 1.19
Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition. J Biol Chem (1999) 1.19
UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions. J Biol Chem (2000) 1.18
The phorbol ester, TPA inhibits glucagon-stimulated adenylate cyclase activity. FEBS Lett (1984) 1.18
Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. Biochem J (1995) 1.17
Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver. Twenty-second Colworth medal lecture. Biochem Soc Trans (1986) 1.17
Kinetic studies of bovine liver carbamoyl phosphate synthetase. Biochem J (1974) 1.16
Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3). Two N-terminal domains are required for the efficient targeting to, and association of, PDE3 with endoplasmic reticulum. J Biol Chem (2000) 1.16
The prosthetic groups of pig brain mitochondrial monoamine oxidase. Biochim Biophys Acta (1968) 1.15
Guanosine 5'-triphosphate and guanosine 5'-[beta gamma-imido]triphosphate effect a collision coupling mechanism between the glucagon receptor and catalytic unit of adenylate cyclase. Biochem J (1980) 1.14
Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family. Biochem J (1995) 1.14
Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes. J Mol Cell Cardiol (2011) 1.14
Thrombin, unlike vasopressin, appears to stimulate two distinct guanine nucleotide regulatory proteins in human platelets. Biochem J (1986) 1.13
Islet-activating protein blocks glucagon desensitization in intact hepatocytes. Biochem J (1984) 1.13
An automatic apparatus for the study of enzyme kinetics. Biochem J (1969) 1.12
The oxidation and reductn of glyoxylate by lactic dehydrogenase. Eur J Biochem (1969) 1.12
Treatment of intact hepatocytes with either the phorbol ester TPA or glucagon elicits the phosphorylation and functional inactivation of the inhibitory guanine nucleotide regulatory protein Gi. FEBS Lett (1989) 1.12
Guanine nucleotides can activate the insulin-stimulated phosphodiesterase in liver plasma membranes. FEBS Lett (1983) 1.11
Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Biochem Pharmacol (1989) 1.11
An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrations. Biochem J (1984) 1.10
The effect of pH on the kinetics of beef-liver fructose bisphosphatase. Eur J Biochem (1975) 1.09
The purification of fructose 1,6-diphosphatase from ox liver and its activation by ethylenediaminetetra-acetate. Biochem J (1975) 1.09
Identification of a surface on the beta-propeller protein RACK1 that interacts with the cAMP-specific phosphodiesterase PDE4D5. Cell Signal (2001) 1.09
Pig liver pyruvate carboxylase. The reaction pathway for the carboxylation of pyruvate. Biochem J (1974) 1.09
Membrane phosphorylation: a crucial role in the action of insulin, EGF, and pp60src? Biosci Rep (1981) 1.08
pH-activity curves for enzyme-catalysed reactions in which the hydron is a product or reactant. Biochem J (1987) 1.08
Is the receptor-mediated endocytosis of cholera toxin A pre-requisite for its activation of adenylate cyclase in intact rat hepatocytes? FEBS Lett (1981) 1.07
The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline. Biochem Pharmacol (1982) 1.07
The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.07
Diabetes abolishes the GTP-dependent, but not the receptor-dependent inhibitory function of the inhibitory guanine-nucleotide-binding regulatory protein (Gi) on adipocyte adenylate cyclase activity. Biochem J (1990) 1.07
Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver. Biochem J (1986) 1.06
The characterization of two reduced nicotinamide-adenine dinucleotide phosphate-linked aldehyde reductases from pig brain. Biochem J (1972) 1.06
Alternative splicing of cAMP-specific phosphodiesterase mRNA transcripts. Characterization of a novel tissue-specific isoform, RNPDE4A8. J Biol Chem (1996) 1.05
The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity. Biochem J (1987) 1.05
Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart. J Mol Cell Cardiol (1997) 1.05
Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase. Biochem Pharmacol (1981) 1.05
The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phospholipid metabolism. Biochem J (1987) 1.04
The purification and properties of the NAD-linked aldehyde dehydrogenase from pig brain. Eur J Biochem (1971) 1.04
Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3. Biochem J (1997) 1.04
Allotopic properties of human brain monoamine oxidase. Nat New Biol (1973) 1.04
Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain. J Neurochem (1982) 1.04
The reaction pathway of membrane-bound rat liver mitochondrial monoamine oxidase. Biochem J (1973) 1.03